Action

Availability

Spray solution: 25 ml (each actuation delivers approximately 25 mcg)

⊘Indications and dosages

➣ Relief of seasonal or perennial rhinitis

Adults: Two sprays in each nostril b.i.d.; may increase to two sprays in each nostril t.i.d. Maximum daily dose is eight sprays in each nostril. For maintenance, after desired clinical effect occurs, reduce dosage to smallest amount needed to control symptoms.

Children ages 6 to 14: One spray in each nostril t.i.d. or two sprays in each nostril b.i.d.; maximum daily dose is four sprays in each nostril. For maintenance, after desired clinical effect occurs, reduce dosage to smallest amount needed to control symptoms.

Contraindications

• Hypersensitivity to drug or its components• Untreated local infections of nasal mucosa

Patient monitoring

Patient teaching

☞ Teach patient to recognize and immediately report serious adverse reactions.• Teach patient proper use of drug. Caution him not to use more than prescribed amount; doing so may cause serious side effects.• Tell patient maximum drug effects may not occur for several weeks.• Tell patient to avoid people with measles, chickenpox, and other transmissible infections.• Caution patient to withhold dose and contact prescriber if infection occurs.• Instruct female patient to tell prescriber if she becomes pregnant.• Tell female patient not to breastfeed without consulting prescriber.• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the tests mentioned above.

flunisolide

flunisolide

A corticosteroid, C24H31FO6, administered by inhalation to treat asthma and nasally to treat allergies.

flunisolide

an intranasal and oral inhalation adrenal corticosteroid.

indications It is prescribed in the treatment of seasonal or continuing allergic rhinitis that involves inflammation of the mucous membranes of the nasal passages and for the treatment of asthma.

contraindications It should not be given to patients with allergy to this drug or any of its components or to patients with status asthmaticus or untreated bacterial, viral, or fungal infections of the respiratory tract or nasal mucosa.

adverse effects The side effects most often reported include nasal or throat irritation, stinging, burning, or dryness; nosebleed; sneezing; bloody mucus; congestion; asthma; increased coughing; sore throat; or lesions in the nose or throat.

flunisolide

Aerobid® An inhalant corticosteroid used to manage asthma

flunisolide

A CORTICOSTEROID drug used in the form of a spray to treat hay fever. A brand name is Syntaris.

The therapeutic indications of NASACORT HFA and AEROSPAN are complementary and will enable us to provide a highly targeted commercial effort directed toward respiratory and pediatric physicians," stated John Simon of Acton Pharmaceuticals.

Treatment with orally inhaled corticosteroids including AEROSPAN, may lead to signs or symptoms of hypercorticism, suppression of hypothalamic-pituitary -adrenal (HPA) function and/or suppression of growth in children.

We are also anticipating that the approval of Aerospan for asthma may occur this year and that the approval of memantine for the treatment of moderate to severe Alzheimer's may occur early next fiscal year.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.